Cargando…
Multiple cycles of intermittent chemotherapy in metastatic androgen-independent prostate cancer
Recently, completed phase III studies demonstrated a survival benefit for a fixed number of cycles of docetaxel-containing chemotherapy treatment of androgen-independent prostate cancer (AIPC). Management of patients who respond well to initial chemotherapy for AIPC remains ill-defined. We previousl...
Autores principales: | Beer, T M, Garzotto, M, Henner, W D, Eilers, K M, Wersinger, E M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409932/ https://www.ncbi.nlm.nih.gov/pubmed/15467765 http://dx.doi.org/10.1038/sj.bjc.6602198 |
Ejemplares similares
-
Intermittent chemotherapy in metastatic androgen-independent prostate cancer
por: Beer, T M, et al.
Publicado: (2003) -
A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
por: Shamash, J, et al.
Publicado: (2008) -
Androgenic properties of the dietary supplement 5α-hydroxy-laxogenin
por: Beer, Carolin, et al.
Publicado: (2022) -
Intermittent Catheterization: The Devil Is in the Details
por: Christison, Kathleen, et al.
Publicado: (2018) -
Endothelial Cells as Precursors for Osteoblasts in the Metastatic Prostate Cancer Bone
por: Paiva, Ana E., et al.
Publicado: (2017)